Effect of duplex drugs linking 2′-deoxy-5-fluorouridine (5-FdU) with 3′-C-ethynylcytidine (ECyd) on hepatoblastoma cell lines
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of duplex drugs linking 2′-deoxy-5-fluorouridine (5-FdU) with 3′-C-ethynylcytidine (ECyd) on hepatoblastoma cell lines
Authors
Keywords
Hepatoblastoma, Duplex drugs, 2′-deoxy-5-fluorouridine, 3′-C-ethynylcytidine
Journal
PEDIATRIC SURGERY INTERNATIONAL
Volume 29, Issue 2, Pages 121-127
Publisher
Springer Nature
Online
2012-11-29
DOI
10.1007/s00383-012-3192-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cytotoxicity of new duplex drugs linking 3′-C-ethynylcytidine and 5-fluor-2′-deoxyuridine against human melanoma cells
- (2012) Sarah Schott et al. INTERNATIONAL JOURNAL OF CANCER
- Characterisation of the Cell Line HC-AFW1 Derived from a Pediatric Hepatocellular Carcinoma
- (2012) Sorin Armeanu-Ebinger et al. PLoS One
- The BH3 mimetic ABT-737 increases treatment efficiency of paclitaxel against hepatoblastoma
- (2011) Justus Lieber et al. BMC CANCER
- Apoptosis sensitizers enhance cytotoxicity in hepatoblastoma cells
- (2011) Justus Lieber et al. PEDIATRIC SURGERY INTERNATIONAL
- Cytostatic activity of the duplex drug linking 2′-deoxy-5-fluorouridine (5FdU) with 3′-C-ethynylcytidine (ECyd) against gastric adenocarcinoma cell lines
- (2010) Jürgen Weinreich et al. INVESTIGATIONAL NEW DRUGS
- Successful Treatment of Childhood High-Risk Hepatoblastoma With Dose-Intensive Multiagent Chemotherapy and Surgery: Final Results of the SIOPEL-3HR Study
- (2010) József Zsíros et al. JOURNAL OF CLINICAL ONCOLOGY
- Inhibition of Bcl-2 and Bcl-X enhances chemotherapy sensitivity in hepatoblastoma cells
- (2010) Justus Lieber et al. PEDIATRIC BLOOD & CANCER
- Synthesis and in vitro activities of new anticancer duplex drugs linking 2′-deoxy-5-fluorouridine (5-FdU) with 3′-C-ethynylcytidine (ECyd) via a phosphodiester bonding
- (2009) Herbert Schott et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Cellular pharmacology of multi- and duplex drugsconsisting of ethynylcytidine and 5-fluoro-2′-deoxyuridine
- (2009) Irene V. Bijnsdorp et al. INVESTIGATIONAL NEW DRUGS
- ATP chemosensitivity testing of new antitumor duplex drugs linking 3`-C-ethynylycytidine (ECyd) and 2´-deoxy-5-fluorouridine (5-FdU) in comparison to standard cytostatica and combinations thereof
- (2009) Sarah Schott et al. INVESTIGATIONAL NEW DRUGS
- Cisplatin versus Cisplatin plus Doxorubicin for Standard-Risk Hepatoblastoma
- (2009) Giorgio Perilongo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adenovirus-mediated cytosine deaminase/5-fluorocytosine suicide gene therapy of human hepatoblastoma in vitro
- (2009) Steven W. Warmann et al. PEDIATRIC BLOOD & CANCER
- Hepatic Stem-like Phenotype and Interplay of Wnt/β-Catenin and Myc Signaling in Aggressive Childhood Liver Cancer
- (2008) Stefano Cairo et al. CANCER CELL
- Role of RNase L in apoptosis induced by 1-(3-C-ethynyl-β-d-ribo-pentofuranosyl)cytosine
- (2008) Tomoharu Naito et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started